Dr Ruchi Gupta shares key updates including a new anaphylaxis definition, treatment advances, and emerging biologics for CSU.
Dr Gupta attended the 2025 AAAAI/WAO meeting in San Diego, highlighting new insights into anaphylaxis, angioedema, and urticaria. A key highlight was the consensus statement refining the ...
an antibody therapy targeting c-Kit to treat mast cell-driven diseases like chronic spontaneous urticaria (CSU) and asthma, at the AAAAI 2025 Annual Meeting in San Diego. The new data, from a ...
Inc. (SPRY), a biopharmaceutical company focused on allergic reaction therapies, announced on Tuesday its participation in the 2025 American Academy of Allergy, Asthma, and Immunology or AAAAI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results